Literature DB >> 20016853

Dendritic cell modulation as a new interventional approach for the treatment of asthma.

Vincent Lombardi1, Omid Akbari.   

Abstract

Dendritic cells (DCs) have a central role in the immune system, as they control the adaptive immune response and mediate both protective immunity and the maintenance of immune tolerance to self antigens. In this review, we will summarize the recent advances regarding the subsets of DCs and how they regulate the differentiation of naive CD4(+) T cells towards different populations of T helper cells. We will particularly describe the role of DCs in the development and regulation of allergic diseases and asthma, and discuss the capacity of DCs to induce proallergenic Th2 cells versus regulatory T cells. Undoubtedly, tolerogenic DCs play a crucial role in the induction of regulatory cells. Understanding the biology of these cells will help us design novel strategies to cure or prevent allergic diseases and asthma. Copyright 2009 Prous Science, S.A.U. or its licensors. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20016853      PMCID: PMC2845716     

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  76 in total

1.  Development of CD8alpha-positive dendritic cells from a common myeloid progenitor.

Authors:  D Traver; K Akashi; M Manz; M Merad; T Miyamoto; E G Engleman; I L Weissman
Journal:  Science       Date:  2000-12-15       Impact factor: 47.728

2.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.

Authors:  Heon Park; Zhaoxia Li; Xuexian O Yang; Seon Hee Chang; Roza Nurieva; Yi-Hong Wang; Ying Wang; Leroy Hood; Zhou Zhu; Qiang Tian; Chen Dong
Journal:  Nat Immunol       Date:  2005-10-02       Impact factor: 25.606

3.  Direct regulatory immune activity of lactic acid bacteria on Der p 1-pulsed dendritic cells from allergic patients.

Authors:  Pierre Pochard; Hamida Hammad; Céline Ratajczak; Anne-Sophie Charbonnier-Hatzfeld; Nicolas Just; André-Bernard Tonnel; Joël Pestel
Journal:  J Allergy Clin Immunol       Date:  2005-07       Impact factor: 10.793

4.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

5.  Signaling through OX40 (CD134) breaks peripheral T-cell tolerance.

Authors:  P Bansal-Pakala; A G Jember; M Croft
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

6.  Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells.

Authors:  A Iwasaki; B L Kelsall
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

7.  Differential capacity of CD8+ alpha or CD8- alpha dendritic cell subsets to prime for eosinophilic airway inflammation in the T-helper type 2-prone milieu of the lung.

Authors:  H Hammad; V C de Vries; R Maldonado-Lopez; M Moser; C Maliszewski; H C Hoogsteden; B N Lambrecht
Journal:  Clin Exp Allergy       Date:  2004-12       Impact factor: 5.018

8.  Paradoxical role of programmed death-1 ligand 2 in Th2 immune responses in vitro and in a mouse asthma model in vivo.

Authors:  Ezogelin Oflazoglu; David A Swart; Penny Anders-Bartholo; Heidi K Jessup; Anne M Norment; William A Lawrence; Kenneth Brasel; Joel E Tocker; Tom Horan; Andrew A Welcher; David R Fitzpatrick
Journal:  Eur J Immunol       Date:  2004-12       Impact factor: 5.532

9.  Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40.

Authors:  A G Jember; R Zuberi; F T Liu; M Croft
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307

10.  Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

Authors:  T Takahashi; T Tagami; S Yamazaki; T Uede; J Shimizu; N Sakaguchi; T W Mak; S Sakaguchi
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

View more
  3 in total

Review 1.  Trial watch: Dendritic cell-based anticancer therapy.

Authors:  Norma Bloy; Jonathan Pol; Fernando Aranda; Alexander Eggermont; Isabelle Cremer; Wolf Hervé Fridman; Jitka Fučíková; Jérôme Galon; Eric Tartour; Radek Spisek; Madhav V Dhodapkar; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-21       Impact factor: 8.110

Review 2.  The complex and evolving story of T cell activation to AAV vector-encoded transgene products.

Authors:  Lauren E Mays; James M Wilson
Journal:  Mol Ther       Date:  2010-11-30       Impact factor: 11.454

Review 3.  Trial watch: Dendritic cell-based interventions for cancer therapy.

Authors:  Erika Vacchelli; Ilio Vitale; Alexander Eggermont; Wolf Hervé Fridman; Jitka Fučíková; Isabelle Cremer; Jérôme Galon; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-07-29       Impact factor: 8.110

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.